Citigroup
DRMA icon

Citigroup’s Dermata Therapeutics DRMA Stock Holding History

Citigroup’s Portfolio DRMA Stock Details DRMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1 Buy
+1
New +$2 ﹤0.01% 5856
2025
Q3 		– Sell
-6
Closed -$35 – 6153
2025
Q2 		$35 Buy
+6
New +$46 ﹤0.01% 5548
2022
Q3 		– Sell
-20
Closed -$32K – 5942
2022
Q2 		$32K Buy
+20
New +$41.2K ﹤0.01% 4752

Other funds holding DRMA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return